Rani Therapeutics Holdings, Inc. (RANI) Financials

RANI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 60.8 million 12.9 million
March 31, 2026 51.9 million 16.3 million
Dec. 31, 2025 58.6 million 17.1 million
Sept. 30, 2025 10.1 million 22.1 million

RANI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.1 million 2.4 million
March 31, 2026 -6.5 million 2.1 million
Dec. 31, 2025 294000 2.2 million
Sept. 30, 2025 -5.1 million 2.3 million

RANI Net Income

No data available :(

RANI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 53.4 million - -
March 31, 2026 43.4 million - 3.9 million
Dec. 31, 2025 49.7 million - 4.3 million
Sept. 30, 2025 4.1 million - 4.0 million

RANI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 187.2 million
March 31, 2026 180.0 million
Dec. 31, 2025 147.1 million
Sept. 30, 2025 36.5 million

RANI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 32000 5.0 million 5.5 million -
March 31, 2026 15000 5.2 million 4.9 million -
Dec. 31, 2025 - 4.9 million 5.1 million -
Sept. 30, 2025 - 3.2 million 4.0 million -

RANI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.7 million -
March 31, 2026 1.7 million 161000
Dec. 31, 2025 1.5 million 186000
Sept. 30, 2025 - 223000

RANI

Price: $0.88

52 week price:
0.44
3.87

Earnings Per Share: -0.13 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 116.0 million

Links: